HCA Healthcare reported Q2 revenue of $20.230 billion, up 8.7% year over year, with net income of $1.699 billion and diluted EPS of $7.62, and adjusted EPS of $7.59. Adjusted EBITDA rose 4.6% to $4.027 billion, while operating cash flow declined to $2.335 billion. The company kept its 2026 GAAP EPS guidance at $28.70 to $30.50, noting higher uninsured volumes and lower surgical activity. Analysts from Wells Fargo and Barclays cut price targets on HCA after softer Q2 results and revised 2026 guidance, though some expect a later reacceleration in organic growth. HCA operates about 189 hospitals and 2,600 ambulatory sites across 19 states and the UK, and recently agreed to acquire the College of Health Care Professions as part of its workforce development strategy. The stock edged higher following the results, reflecting the mixed near-term outlook.